Hib-DTP-acellular vaccine (Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHib-DTP-acellular vaccine (Pfizer)

Drug Alias NameHib-DTP-acellular vaccine - Wyeth VaccinesTetracel

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccineVaccines > Vaccine type > Combination vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (NDA/BLA)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Other Information

ATC CodeN/A